Neurology News and Research RSS Feed - Neurology News and Research

ADDF awards $2.1 million grant for clinical study of cancer drug in Alzheimer's patients

ADDF awards $2.1 million grant for clinical study of cancer drug in Alzheimer's patients

The Alzheimer's Drug Discovery Foundation announces a $2.1 million grant awarded to R. Scott Turner, MD, PhD, of Georgetown University Medical Center to conduct a phase II clinical trial of low-dose nilotinib (marketed as Tasigna for use as a cancer therapy) in patients with Alzheimer's disease. [More]
UVA researchers begin first clinical trial using focused ultrasound to treat patients with epilepsy

UVA researchers begin first clinical trial using focused ultrasound to treat patients with epilepsy

Researchers at the University of Virginia are starting the first clinical trial in the world using focused ultrasound to treat patients with epilepsy. [More]
Promedica partners with Kaonsoft to accelerate development of new mobile healthcare apps

Promedica partners with Kaonsoft to accelerate development of new mobile healthcare apps

ProMedica, one of Ohio's largest healthcare systems, is partnering with Kaonsoft, an enterprise mobility software company, to form Kapios Health, a healthcare technology company that will focus on the development of medical applications created by ProMedica Innovations inventors. [More]
Study finds no evidence that exercise may lower woman’s risk of developing MS

Study finds no evidence that exercise may lower woman’s risk of developing MS

A large, new study shows no evidence that exercise may reduce a woman's risk of developing multiple sclerosis (MS). [More]
Experimental PET tracer can diagnose concussion-related brain degeneration in living person

Experimental PET tracer can diagnose concussion-related brain degeneration in living person

An experimental positron emission tomography (PET) tracer can effectively diagnose concussion-related brain degeneration while a person is still alive, according to a proof-of-concept study conducted at the Icahn School of Medicine at Mount Sinai and published September 27 in the journal Translational Psychiatry. [More]
Researchers identify process in the brains of mice that may explain repetitive actions in Rett patients

Researchers identify process in the brains of mice that may explain repetitive actions in Rett patients

Three-year-old Naomi slaps her forehead a few times, bites her fingers and toddles across the doctor's office in her white and pink pajamas before turning her head into a door with a dull thud. [More]
Unknown exposure to second-hand smoke linked to increased mortality in non-smokers

Unknown exposure to second-hand smoke linked to increased mortality in non-smokers

A new biomarker has identified known and unknown exposure to second-hand smoke and confirmed a strong association to increased mortality in non-smokers, according to a new study from the Icahn School of Medicine at Mount Sinai. [More]
Children's Hospital of Michigan wins Excellence through Insight award for exceptional pediatric care

Children's Hospital of Michigan wins Excellence through Insight award for exceptional pediatric care

The Children's Hospital of Michigan, part of the Detroit Medical Center was recently recognized with an Excellence through Insight award for "Overall Outpatient Surgery Experience" in the Pediatrics Unit Category by HealthStream, Inc. [More]
Skin phenotype of pediatric eczema opens door for personalized treatment of AD in infants

Skin phenotype of pediatric eczema opens door for personalized treatment of AD in infants

Researchers for the first time have identified the skin phenotype of pediatric eczema or atopic dermatitis (AD) in infants, opening the door for personalized treatment approaches for young children with eczema. [More]
New study to examine effectiveness of orally administered drug in treating stuttering

New study to examine effectiveness of orally administered drug in treating stuttering

Stuttering, an interruption in the flow of speech, affects about three million Americans. It begins most often in childhood, affecting four men for every woman. A precise cause of this complex communicative disorder is not known. [More]
Experimental drug may prevent development of multiple sclerosis in mice

Experimental drug may prevent development of multiple sclerosis in mice

The experimental drug laquinimod may prevent the development or reduce the progression of multiple sclerosis (MS) in mice, according to research published in the September 21, 2016, online issue of Neurology Neuroimmunology & Neuroinflammation, a medical journal of the American Academy of Neurology. [More]
Mount Sinai and TJU researchers awarded grant for UM research

Mount Sinai and TJU researchers awarded grant for UM research

Uveal melanoma (UM) is the second most common type of skin cancer. Approximately 50 percent of patients will develop metastasis or spread of their cancer, most commonly to the liver. [More]
MR Solutions receives order for cryogen-free 7T simultaneous PET-MR preclinical imaging system

MR Solutions receives order for cryogen-free 7T simultaneous PET-MR preclinical imaging system

MR Solutions has received an order for a high-powered 7T, cryogen-free, preclinical PET-MRI multi-modality imaging system from the newly formed pre-clinical imaging resource at the Zilkha Neurogenetic Institute (ZNI) at the Keck School of Medicine of the University of Southern California (USC). [More]
ECTRIMS, EAN collaborate to develop new therapeutic guidelines for MS

ECTRIMS, EAN collaborate to develop new therapeutic guidelines for MS

The 32nd Congress of the European Committee for Treatment and Research in Multiple Sclerosis (MS) concluded today in London (September 14-17) and one of the late breaking sessions presented the Clinical Guideline on the pharmacological management of people with Multiple Sclerosis developed jointly by ECTRIMS and European Academy of Neurology (EAN). [More]
CHOP researchers exploit gene discovery in severe epilepsy to identify precision treatment

CHOP researchers exploit gene discovery in severe epilepsy to identify precision treatment

An international team of researchers who discovered a new gene disorder that causes severe childhood epilepsy leveraged that finding to reduce seizures in two children. [More]
Study shows continuous electrical stimulation suppresses seizures in patients with epilepsy

Study shows continuous electrical stimulation suppresses seizures in patients with epilepsy

When surgery and medication don't help people with epilepsy, electrical stimulation of the brain has been a treatment of last resort. [More]
Researchers reveal previously unknown role of glutamate in neuromuscular development

Researchers reveal previously unknown role of glutamate in neuromuscular development

For decades, scientists thought acetylcholine was the only neurotransmitter responsible for controlling how muscles and nerves are wired together during development. [More]
Study shows clot-busting drug safe in treating people with wake-up stroke

Study shows clot-busting drug safe in treating people with wake-up stroke

Using a clot-busting medication to treat people who wake up with symptoms of stroke was safe and should be studied further to see how effective it might be for a population that otherwise has few treatment options, according to researchers at The University of Texas Health Science Center at Houston. [More]
Karger publishes new clinical guide on management of chronic itch

Karger publishes new clinical guide on management of chronic itch

Although it is such a common symptom in dermatology, internal medicine, psychosomatics, neurology, and even oncology, itching was under-researched up until 15 years ago. Since then, the clinical aspects of acute and chronic itch have been examined extensively. A new clinical guide on how to manage itch has just been published by Karger. [More]
Epilepsy Foundation launches new campaign to raise awareness of SUDEP among people with epilepsy

Epilepsy Foundation launches new campaign to raise awareness of SUDEP among people with epilepsy

In response to the urgent need to raise awareness of Sudden Unexpected Death in Epilepsy (SUDEP) among people with epilepsy and their caregivers, the Epilepsy Foundation’s SUDEP Institute today issued a special expert consensus report, #AimForZero: Striving Toward a Future Free from Sudden Unexpected Death in Epilepsy. [More]
Advertisement
Advertisement